Leflunomide and Hemianopia homonymous - a phase IV clinical study of FDA data

Summary:

Hemianopia homonymous is reported as a side effect among people who take Leflunomide (leflunomide), especially for people who are female, 60+ old, also take Humira, and have Cardiac disorder.

The phase IV clinical study analyzes which people have Hemianopia homonymous when taking Leflunomide. It is created by eHealthMe based on reports of 81,713 people who have side effects when taking Leflunomide from the FDA, and is updated regularly.

What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 82,105 Leflunomide users. Check the latest studies of Leflunomide.

What is Hemianopia homonymous?

Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes) is found to be associated with 160 drugs and 272 conditions by eHealthMe. Check the latest studies of Hemianopia homonymous.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

81,713 people reported to have side effects when taking Leflunomide.
Among them, 11 people (0.01%) have Hemianopia homonymous.

Could Leflunomide cause Hemianopia homonymous?

Among these 11 people:

What is the gender of people who have Hemianopia homonymous when taking Leflunomide? *

  • female: 90 %
  • male: 10 %

What is the age of people who have Hemianopia homonymous when taking Leflunomide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Leflunomide? *

  1. Humira: 4 people, 36.36%
  2. Vitamin D3: 2 people, 18.18%
  3. Hydrocodone Bitartrate And Acetaminophen: 2 people, 18.18%
  4. Protonix: 2 people, 18.18%
  5. Centrum Silver: 2 people, 18.18%
  6. Plaquenil: 2 people, 18.18%
  7. Pantoprazole: 2 people, 18.18%
  8. Celecoxib: 1 person, 9.09%
  9. Clopidogrel: 1 person, 9.09%
  10. Cyclosporine: 1 person, 9.09%

What are other side effects people have besides Hemianopia homonymous? *

  1. Memory Loss: 7 people, 63.64%
  2. Hemiplegia (paralysis of one side of the body): 6 people, 54.55%
  3. Altered State Of Consciousness (altered state of mind): 5 people, 45.45%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 45.45%
  5. Disturbance In Attention: 5 people, 45.45%
  6. Encephalitis (inflammation of the brain): 4 people, 36.36%
  7. Weakness: 4 people, 36.36%
  8. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 3 people, 27.27%
  9. Anti-Cyclic Citrullinated Peptide Antibody Positive: 3 people, 27.27%
  10. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 3 people, 27.27%

What are the existing conditions these people have? *

  1. Stress And Anxiety: 2 people, 18.18%
  2. Pain: 2 people, 18.18%
  3. Insomnia (sleeplessness): 2 people, 18.18%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
  5. Gastric Disorder (disease of stomach): 2 people, 18.18%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 18.18%
  7. Cardiac Disorder: 2 people, 18.18%
  8. Analgesic Effect: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Leflunomide and have Hemianopia homonymous?

- Check whether Hemianopia homonymous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Leflunomide:

Hemianopia homonymous treatments and more:

How severe was Hemianopia homonymous and when was it recovered:

Expand to all the drugs that have ingredients of leflunomide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hemianopia homonymous:

Browse all the conditions that are associated with Hemianopia homonymous:


How the study uses the data?

The study uses data from the FDA. It is based on leflunomide (the active ingredients of Leflunomide) and Leflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: